⌘K

Login Start Free

Home/Filings/4/0001209191-21-053469

4//SEC Filing

Hegde Priti 4

Accession 0001209191-21-053469

CIK 0001750019other

View on SEC.gov Company Profile

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 4:21 PM ET

Size

5.3 KB

Accession

0001209191-21-053469

Insider Transaction Report

Form 4

Period: 2021-08-25

TCR2 THERAPEUTICS INC.TCRR

Director

Transactions

Award
Stock Option (Right to Buy)
2021-08-25+24,968→ 24,968 total
Exercise: $16.02Exp: 2031-08-24→ Common Stock (24,968 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on August 25, 2022, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1

filerCIK 0001880034

Filing Metadata

Form type: 4
Filed: Aug 25, 8:00 PM ET
Accepted: Aug 26, 4:21 PM ET
Size: 5.3 KB

View on SEC.gov